annual D&A:
$322.54M+$123.99M(+62.45%)Summary
- As of today (June 22, 2025), BNTX annual depreciation & amortization is $322.54 million, with the most recent change of +$123.99 million (+62.45%) on December 31, 2024.
- During the last 3 years, BNTX annual D&A has risen by +$233.56 million (+262.51%).
- BNTX annual D&A is now at all-time high.
Performance
BNTX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$45.04M-$131.67M(-74.51%)Summary
- As of today (June 22, 2025), BNTX quarterly depreciation & amortization is $45.04 million, with the most recent change of -$131.67 million (-74.51%) on March 1, 2025.
- Over the past year, BNTX quarterly D&A has increased by +$3.43 million (+8.26%).
- BNTX quarterly D&A is now -74.51% below its all-time high of $176.71 million, reached on December 31, 2024.
Performance
BNTX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$325.97M+$3.43M(+1.06%)Summary
- As of today (June 22, 2025), BNTX TTM depreciation & amortization is $325.97 million, with the most recent change of +$3.43 million (+1.06%) on March 1, 2025.
- Over the past year, BNTX TTM D&A has increased by +$119.55 million (+57.91%).
- BNTX TTM D&A is now at all-time high.
Performance
BNTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
BNTX Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +62.5% | +8.3% | +57.9% |
| 3 y3 years | +262.5% | +45.4% | +212.6% |
| 5 y5 years | +749.9% | +374.5% | +729.9% |
BNTX Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +262.5% | -74.5% | +49.0% | at high | +212.6% |
| 5 y | 5-year | at high | +749.9% | -74.5% | +374.5% | at high | +729.9% |
| alltime | all time | at high | +2604.9% | -74.5% | +451.8% | at high | +3893.9% |
BNTX Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $45.04M(-74.5%) | $325.97M(+1.1%) |
| Dec 2024 | $322.54M(+62.4%) | $176.71M(+247.4%) | $322.54M(+39.9%) |
| Sep 2024 | - | $50.87M(-4.7%) | $230.50M(+2.7%) |
| Jun 2024 | - | $53.37M(+28.3%) | $224.50M(+8.8%) |
| Mar 2024 | - | $41.60M(-50.9%) | $206.43M(+4.0%) |
| Dec 2023 | $198.55M(+52.7%) | $84.66M(+88.7%) | $198.55M(+33.3%) |
| Sep 2023 | - | $44.86M(+27.1%) | $148.92M(+10.9%) |
| Jun 2023 | - | $35.30M(+4.7%) | $134.29M(+1.1%) |
| Mar 2023 | - | $33.72M(-3.7%) | $132.79M(+2.1%) |
| Dec 2022 | $130.03M(+46.1%) | $35.04M(+15.9%) | $130.03M(+3.2%) |
| Sep 2022 | - | $30.23M(-10.5%) | $125.96M(+6.5%) |
| Jun 2022 | - | $33.79M(+9.1%) | $118.31M(+13.4%) |
| Mar 2022 | - | $30.97M(+0.0%) | $104.28M(+17.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $88.98M(+101.3%) | $30.97M(+37.2%) | $88.98M(+24.3%) |
| Sep 2021 | - | $22.58M(+14.2%) | $71.57M(+18.4%) |
| Jun 2021 | - | $19.77M(+26.2%) | $60.47M(+20.0%) |
| Mar 2021 | - | $15.67M(+15.5%) | $50.37M(+14.0%) |
| Dec 2020 | $44.20M(+16.5%) | $13.56M(+18.2%) | $44.20M(+5.7%) |
| Sep 2020 | - | $11.48M(+18.6%) | $41.81M(+5.6%) |
| Jun 2020 | - | $9.67M(+1.9%) | $39.59M(+0.8%) |
| Mar 2020 | - | $9.49M(-15.0%) | $39.28M(+3.5%) |
| Dec 2019 | $37.95M(+46.2%) | $11.17M(+20.6%) | $37.95M(+41.7%) |
| Sep 2019 | - | $9.26M(-1.0%) | $26.78M(+52.9%) |
| Jun 2019 | - | $9.36M(+14.7%) | $17.52M(+114.7%) |
| Mar 2019 | - | $8.16M | $8.16M |
| Dec 2018 | $25.96M(+117.7%) | - | - |
| Dec 2017 | $11.92M | - | - |
FAQ
- What is BioNTech SE annual depreciation & amortization?
- What is the all time high annual D&A for BioNTech SE?
- What is BioNTech SE annual D&A year-on-year change?
- What is BioNTech SE quarterly depreciation & amortization?
- What is the all time high quarterly D&A for BioNTech SE?
- What is BioNTech SE quarterly D&A year-on-year change?
- What is BioNTech SE TTM depreciation & amortization?
- What is the all time high TTM D&A for BioNTech SE?
- What is BioNTech SE TTM D&A year-on-year change?
What is BioNTech SE annual depreciation & amortization?
The current annual D&A of BNTX is $322.54M
What is the all time high annual D&A for BioNTech SE?
BioNTech SE all-time high annual depreciation & amortization is $322.54M
What is BioNTech SE annual D&A year-on-year change?
Over the past year, BNTX annual depreciation & amortization has changed by +$123.99M (+62.45%)
What is BioNTech SE quarterly depreciation & amortization?
The current quarterly D&A of BNTX is $45.04M
What is the all time high quarterly D&A for BioNTech SE?
BioNTech SE all-time high quarterly depreciation & amortization is $176.71M
What is BioNTech SE quarterly D&A year-on-year change?
Over the past year, BNTX quarterly depreciation & amortization has changed by +$3.43M (+8.26%)
What is BioNTech SE TTM depreciation & amortization?
The current TTM D&A of BNTX is $325.97M
What is the all time high TTM D&A for BioNTech SE?
BioNTech SE all-time high TTM depreciation & amortization is $325.97M
What is BioNTech SE TTM D&A year-on-year change?
Over the past year, BNTX TTM depreciation & amortization has changed by +$119.55M (+57.91%)